Sandoz bags USFDA approval for biosimilar Tyruko for relapsing forms of multiple sclerosis Ruchika Sharma26 Aug 2023 11:00 AM ISTTyruko has the same intravenous dosage form, route of administration, dosing regimen and presentation as the reference medicine.
Sandoz releases positive results from Mylight Phase lll study for biosimilar Aflibercept Ruchika Sharma16 Aug 2023 3:00 PM ISTAflibercept is a recombinant fusion protein that binds to vascular endothelial growth factor A and placental growth factor (PlGF), inhibiting abnormal...
Patent infringement: Roche sues Novartis unit over generic lung disease drug Ruchika Sharma3 Aug 2023 1:30 PM ISTSwiss drugmaker Roche's Genentech subsidiary has accused a Novartis unit of infringing one of its patents by selling a generic version of its...
Sandoz plans to build Biosimilar Technical Development Center in Slovenia Ruchika Sharma20 July 2023 3:30 PM ISTBasel: Sandoz has announced an investment of approximately USD 90 million at its site in Ljubljana, Slovenia to establish a dedicated Sandoz Biopharma...
Novartis sees Sandoz adding USD 3 billion in net sales over next five years Ruchika Sharma8 Jun 2023 4:30 PM ISTLondon: Novartis' soon-to-be spun off generics division Sandoz is expected to expand its pipeline and potentially generate an additional $3...
Sandoz to move to new central Basel headquarters after spinoff Ruchika Sharma4 Jun 2023 10:00 AM ISTThe move into the new office building will not impact the management of the Sandoz global business.
EMA accepts marketing authorization applications for proposed biosimilar Denosumab: Sandoz Ruchika Sharma28 May 2023 10:00 AM ISTDenosumab is a human monoclonal antibody designed to bind to the RANKL protein, an activator of osteoclasts (cells involved in breaking down bone...
New Sandoz Board of Directors appointed Ruchika Sharma15 May 2023 2:57 PM ISTBasel: The Novartis Board of Directors has approved the recommendations of the Sandoz Chairman-designate, Gilbert Ghostine, on the structure of the...
Sandoz strengthens pipeline expansion through partnership to develop, manufacture multiple biosimilars Ruchika Sharma10 May 2023 3:30 PM ISTBasel: Sandoz has announced a multi-year partnership with Just - Evotec Biologics, the Seattle-based subsidiary of Evotec SE. The agreement covers the...
Novartis division Sandoz to exclusively commercialize six products in US across key therapeutic areas Ruchika Sharma4 May 2023 5:40 PM ISTBasel: Sandoz has announced that it has signed a distribution and collaboration agreement with Adalvo for exclusive Sandoz rights to commercialize six...
Patent infringement: Amgen sues Novartis to block generic osteoporosis, bone cancer drugs Ruchika Sharma3 May 2023 5:30 PM ISTAmgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.
Novartis lifts full year earnings on higher prescriptions Ruchika Sharma25 April 2023 11:37 AM ISTFirst-quarter group sales gained 3 percent to $12.95 billion, above an analyst consensus of $12.55 billion, driven by better than expected revenues...
